{"disease":{"id":"cutaneous-ulcer","name":"cutaneous ulcer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05764876","title":"Repurposing Clinically Approved Drugs for Yaws with an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":465,"lead_sponsor_name":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","has_results":false},{"nct_id":"NCT06690814","title":"Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":370,"lead_sponsor_name":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","has_results":false},{"nct_id":"NCT07264686","title":"Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG - Second Trial","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":222,"lead_sponsor_name":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","has_results":false},{"nct_id":"NCT04453124","title":"An Accessible Low-cost Plant Treatment for Cutaneous Ulcers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Oriol Mitja","has_results":false},{"nct_id":"NCT04030832","title":"Reconstruction of Skin Substance Loss With \"Micro-grafts\" Obtained by Mechanical Disintegration","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Azienda Ospedaliero, Universitaria Ospedali Riuniti","has_results":false},{"nct_id":"NCT03038672","title":"Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":54,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05165628","title":"Safety, Tolerability and Efficacy of CYP-006TK in Adults with Diabetic Foot Ulcers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Cynata Therapeutics Limited","has_results":false},{"nct_id":"NCT04058197","title":"Deferoxamine for Sickle Cell Chronic Leg Ulcer Treatment","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"TauTona Group","has_results":false},{"nct_id":"NCT06730022","title":"Dermacyte® Liquid for Treatment of Cutaneous Ulcers and Wounds","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Merakris Therapeutics","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}